Performers / Professionals From Around The Globe

WASSIL NOWICKY

President Ukrainian Anti-Cancer Institute
Austria

WEISI YAN

Director Cyberknife Program, University of South Alabama
USA

DONGLU SHI

Professor University of Cincinnati
USA

IGOR SMIT

Doctor
Netherlands

ROSARIO DAVALOS

Professor
Bolivia

JOSE ANTONIO MATUTE

Sub medical Director
Mexico

GEORGE KUNUDJI

Doctor
Ghana

MARJAN JALALI MEHR

Doctor
Iran

Prof. Liane Deligdich

Mount Sinai Icahn School of Medicine
USA

Dr. Fabian Schneider

Definiens AG
Germany

Dr. Jens. C. Hahne

the Institute of Cancer Research
UK

HYUN SOO LIM

Chungnam National University
South Korea

Tracks & Key Topics

Academic Key Topics

Business Key Topics

ABOUT WEBINAR

World Webinar on Oncology and Cancer Science welcomes you for the 17th Edition this time as an Online Conference/Webinar scheduled on November 16-17, 2020.

Oncologists Congress 2020 invites all the participants from all over the world which includes prompt Keynote talks, Oral talks, Poster presentations, Sponsor Ships and Exhibitions. The aim of this conference is “Amalgamation of innovations in cancer treatment & Challenges during COVID-19”. Oncologists Congress 2020 is comprised of many interactive scientific sessions as well as various diagnostic and therapeutic advancements in cancer. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of oncology.

Oncologists Congress 2020 webinar is inspirational and energizing opportunity to connect with the greater scientific community, where you get to know about new strategies to approach your research. To contemplate the bigger picture and establish collaborations. A good conference has the capacity to bring a scientist within you; Oncology conferences are very helpful for learning about new areas and publications of Oncology and Cancer.

Oncology Conferences 1000+ CME Global events every year across the globe with support from 1000+ more scientific societies and Publishes 500 Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Who Should Attend??

Oncologists Congress 2020 webinar is a novel discussion to unite overall recognized scholastic Researchers, Public wellbeing experts, Scientists, Doctors, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Pediatric, Physicians, Advocacy, etc., to exchange about the state of the Research and Development.

Target Audience:

Why Should Attend??

The arranging group assembles eminent speakers covering the most recent advances in the field, fusing differing qualities in each sense. We likewise incorporate talks on most recent methodologies for concentrating these biological inquiries.

Exclusive B2B meetings, Interactive Sessions, Panel Discussions, Keynote Sessions, Poster Presentations, Oral Presentations, Workshops, Exhibitions etc., are the main highlights of this event.

Benefits of ONLINE EVENT / WEBINARS:

Scope & Importance:

Oncologists Congress 2020 and Oncology webinars will seam world-class educators, scientists and Oncologists to converse diverse procedures for Cancer treatment, Chemotherapy, and Radiology.

Oncologists Congress 2020 will be the best platform for all the oncologists, hematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability and quality of life.

Overview of Oncologists Congress 2020:

Cancer is an abnormal growth of cells that tend to proliferate in an uncontrolled way, and in some cases, to metastasize / spread. Cancer is not a single or one disease but it is a group of different and distinctive diseases. In all types of cancer, some of the body's cells begin to divide without stopping and spread into surrounding tissues, genetically which are called Oncogenes. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. As cancer is spreading in the world very rapidly so many market studies and researches are going on and still so many are under study.

The Innovative idea of Cancer has started great much research to be embraced by the labs around the world. With such an extraordinary number of researchers and scientists taking a shot at Caner research, to date, no significant solution for this is recorded. Oncologists Congress 2020 will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Oncologists Congress 2020 will also supply the two days of discussions on methods and systems identified with administration and satisfactory exchange of Cancer and in addition to check out the new thoughts and ideas on worldwide scale and the themes include Field Of Oncology, Oncologic Subspecialties, Cancer Cell Biology & Genetics, Tumor Biology, Cancer Metastasis, Stem Cell Therapy in Oncology, Cancer Molecular Diagnostics, The COVID-19 Challenge: Oncology, Medical Oncology, Neuro-Oncology, Radiation Oncology, Surgical Oncology, Hemato-Oncology, Gynaec- Oncology, Clinical Research On Oncology, Precision Cancer Medicine & Oncology, Cancer Biopsy, Immuno-Oncology, Pharmaceutical Oncology, Neonatal & Pediatric Oncology, Oncolytic Virus, Oncogenomics, Oncology Nursing & Care, Cancer Chemotherapy, Nanotechnology In Oncology Treatment, Cancer Awareness, Life-Style & Nutrition, Cancer: Complementary & Alternative Treatments, Advances in Cancer Research And Treatment, Current Research in Cancer.

SESSIONS & TRACKS

Track-1: Field Of Oncology

Oncology is the study of cancer. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer.

The field of oncology has three major areas:

Track-2: Oncologic Subspecialties

There are several sub-specialties in the field of Oncology. The above mentioned specialties deal with the treatment of cancer through Chemotherapy or Immunotherapy, Biopsies and Radiology respectively.

Track-3: Cancer Cell Biology & Genetics

Cell division could be a traditional method utilized by the body for growth and repair. Healthy cells stop dividing once there's not a requirement for additional female offspring cells; however cancer cells still turn out copies. Cancer cells square measure cells that divide unrelentingly, forming solid tumors or flooding the blood with abnormal cells. Cancer biology deals with these changes and also the molecular networks that management cell proliferation, differentiation and death. The study of varied styles of cancer is termed as medical specialty.

Track-4: Tumor Biology

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they can also have other causes. Over 100 types of cancers affect humans.

Track-5: Cancer Metastasis

The spread of cancer from one part of the body to another part or to lymph nodes, which are not directly connected to each other is called cancer metastasis. Cancer is considered as a deadly disease mainly because of its ability to spread in the body. This metastasis takes place through the blood stream or the lymph system. The most common metastasis parts of the body are the lungs, bones, liver and brain. The metastatic cancer cells does not resemble the feature of the cells where it was found but it resembles the primary cancer cells i.e. it was considered as a next stage of the primary cancer cells. All metastatic cancers are considered as advanced cancers. The cancer survival and treatment is influenced by whether the cancer cells are localized or spreads to other parts. When the cancer starts to spread it is very difficult to control. Even if the treatment is continued, it will be only palliative care. The pain killing will be mostly by Anti-cancer drugs such as chemotherapy. Cancer Management is a multidisciplinary approach that deals with the various type of cancer complications and its preventive measures. Cancer Conferences is an important key for both educational and clinical guidance for managing cancer patients.

Track-6: Stem Cell Therapy In Oncology

A stem cell is a cell with the unique ability to develop into specialized cell types in the body. In the future they may be used to replace cells and tissues that have been damaged or lost due to disease.

In stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or serve as a way for the donor's immune system to fight some types of cancer and blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. These transplants use adult stem cells or umbilical cord blood. Stem cells are not only widely used for regenerative medicine, but are also considered as a useful tool for cancer treatment. For a long time, stem cells have been utilized to renew the immune system for radiation or chemo- therapy treated patients.

Track-7: Cancer Molecular Diagnostics

Molecular diagnostics can be used to determine whether a person is at risk for a certain type of cancer. When used this way, the tests may also be referred to as molecular profiling or molecular risk assessment. These tests help a person determine how likely he or she is to develop cancer.

Track-8: The COVID-19 Challenge: Oncology

The recent Chinese experience suggests that cancer patients are at higher risk of infection to SARS-CoV-2 compared to the general population, which could be related to the closer medical follow-up organized in such fragile patients. More concerning, the risk of severe respiratory complications requiring intensive care unit was much higher in cancer patients compared to non-cancer patients. A covariate significantly associated with this risk was a history of chemotherapy or surgery in the previous months, a feature that involves the highest number of cancer patients. Finally, the cancer patients deteriorated more rapidly than those without cancer.

Track-9: Medical Oncology

Medical oncologists are doctors who treat patients with a balance of radiotherapy and chemotherapy. They are involved in the management of all types of cancer and use a range of other treatments to treat cancers, without using surgery.

They are different than medical oncologists, who use non-radiological treatments for cancer. Clinical oncologists determine which treatment to use by considering a range of factors such as the type of tumor, tumor site, the stage of the disease and the patient’s general health. They assess the relative merits of different treatments before presenting these to the patient.

Track-10: Neuro-Oncology

In biology, cell signaling is part of any communication process that governs basic activities of cells and coordinates multiple-cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity, as well as normal tissue homeostasis. Errors in signaling interactions and cellular information processing may cause diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, clinicians may treat diseases more effectively and, theoretically, researchers may develop artificial tissues.

All cells receive and respond to signals from their surroundings. This is accomplished by a variety of signal molecules that are secreted or expressed on the surface of one cell and bind to a receptor expressed by the other cells, thereby integrating and coordinating the function of the many individual cells that make up organisms. Each cell is programmed to respond to specific extracellular signal molecules. Extracellular signaling usually entails the following steps:

Track-11: Radiation Oncology

Radiology is the medical discipline that uses medical imaging to diagnose and treat diseases within the bodies of both humans and animals. A variety of imaging techniques such as X-ray radiography, ultrasound, computed tomography (CT), nuclear medicine including positron emission tomography (PET), and magnetic resonance imaging (MRI) are used to diagnose or treat diseases. Interventional radiology is the performance of usually minimally invasive medical procedures with the guidance of imaging technologies such as those mentioned above.

Track-12: Surgical Oncology

Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors.

As one of several modalities in the management of cancer, the specialty of surgical oncology, before modern medicine the only cancer treatment with a chance of success, has evolved in steps similar to medical oncology (pharmacotherapy for cancer), which grew out of hematology, and radiation oncology, which grew out of radiology.

Track-13: Hemato-Oncology

A hematologist-oncologist is a physician, specializes in diagnosing, treatment and prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. This physician is trained in hematology — the study of blood — and oncology — the study of cancer.

Track-14: Gynaec- Oncology

Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework.

Track-15: Clinical Research On Oncology

A case study is a research method involving an up-close, in-depth, and detailed examination of a concerned case (subject/topic), as well as its related contextual conditions. Case studies can be produced by a formal research method followed by an individual, organization, event, or action, existing in a specific time and place. Here we are inviting case studies based on any types of cancer or related incidents or events with facts and figures. Presenting your studies on any other type of cancer in this category will privilege you with a 30% discount on registration.

Track-16: Precision Cancer Medicine & Oncology

Precision medicine (PM) is a medical model that proposes the customization of healthcare, with medical decisions, treatments, practices, or products being tailored to the individual patient, instead of a oneâ€drugâ€fitsâ€all model. In precision medicine, diagnostic testing is often employed for selecting appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular or cellular analysis. Tools employed in precision medicine can include molecular diagnostics, imaging, and analytics.

Track-17: Cancer Biopsy

A biopsy is the main way doctors diagnose most types of cancer. Other tests can suggest that cancer is present, but only a biopsy can make a diagnosis. During a biopsy, a doctor removes a small amount of tissue to examine under a microscope.

Track-18: Immuno-Oncology

Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts.

Track-19: Pharmaceutical Oncology

A multidisciplinary way to deal with redesign has been connected in a variety of settings in clinical oncology, especially among patients with stomach and colorectal malignancy. Cancer has one of the highest mortality rates of all diseases worldwide. As a pre-treatment prior to hematopoietic progenitor cell transplantation carried out as a part of treatment for all forms of blood cancer, this drug is contributing to patients as a necessary drug that ranks alongside radiation therapy. Hepatitis B antibody was disease counteractive action antibodies upheld Drug Administration (FDA). Disease treatment immunizations were likewise considered restorative antibodies.

Track-20: Neonatal & Pediatric Oncology

Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are, Neuroblastoma, Retinoblastoma, Wilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment.

Track-21: Oncolytic Virus

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic viruses are thought not only to cause direct destruction of the tumor cells, but also to stimulate host anti-tumor immune system responses. The potential of viruses as anti-cancer agents was first realized in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus, and vaccine have been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumor selectivity, although there are naturally occurring examples such as reovirus and the Seneca virus, resulting in clinical trials.

Track-22: Oncogenomics

Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in cancer. Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation.

Track-23: Oncology Nursing & Care

Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Cancer Summit 2019 will make another transformation in malignancy science and disease nursing field.

Track-24: Cancer Chemotherapy

Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy and synthetic lethality.

Track-25: Nanotechnology In Oncology Treatment

Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterial (such as nanoparticles for tumor imaging or drug delivery) and nanotechnology approaches (such as nanoparticle-based theranostics) to the diagnosis and treatment of cancer.

Track-26: Cancer Awareness, Life-Style & Nutrition

Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet, body weight and physical activity —especially being overweight or obese—are leading risk factors for obtaining certain types of cancer. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles.

Track-27: Cancer: Complementary & Alternative Treatments

Complementary and alternative are terms used to describe many kinds of products, practices, and systems that are not part of mainstream medicine. You may hear them used to refer to methods to help relieve symptoms and improve quality of life during cancer treatment. We call these “complementary” because they are used along with your medical treatment.

Track-28: Advances In Cancer Research And Treatment

Instruments are designed to aid in the diagnosis, monitoring or treatment of medical conditions. Several new types of equipment are used in the treatment of cancer such as:

Linear Accelerator (LINAC) – It emits radiation of highly localised (X-rays) and it is useful in the treatment of cancer. The 6 MeV linear accelerator having the capability of surface electron allows treating cancer cells even under the subcutis layer overlying the cranium. The patient can also see his activity through the connected display unit.

Gamma Camera – It is used in the detection of cancer via gamma rays. Here tracers used are introduced into the patient’s body intravenously, thus getting the image on the gamma camera as the tracer emits gamma rays which are detected by the gamma camera.

Radiography and Ultrasound – It is a non-invasive way of getting the image of the internal organs by ultrasound. It is a useful method for cancer patients for examining the abdomen for any enlargement of the lymph or masses.

Track-29: Current Research In Cancer

Leukemia, Lymphoma, Germ cell tumors and early stage solid tumors which were once incurable have become curable malignancies now. Immunotherapies have already proven efficient in leukemia, bladder cancer and various skin cancers. For the future, research is promising in the field of physical oncology. Survival of cancer has significantly improved over the past years due to improved screening, diagnostic methods and treatment options with targeted therapy. Large multi-centric Phase III randomized controlled clinical trials by the National Surgical Adjuvant Breast & Bowel Project (NSABP), Medical Research Council (MRC), and the European Organization for Research and Treatment of Cancer (EORTC) and National Cancer Institute (NCI) have contributed significantly to the improvement in survival.

MARKET ANALYSIS

According to the journal published by Biomed Central, rotavirus infection the leading cause of severe dehydrating diarrhea among children worldwide. Every year rotavirus infection causes an estimated 111 million diarrhea episodes leading to 2 million hospitalization cases and 400,000 deaths of children under 5 years. Out of all these 82% occur in children in the poorest countries of Asia and Africa. As per Centers for Disease Control and Prevention (CDC), chronic HBV affected almost 1.4 million of the US population in 2011 and acting as major public health challenge. In past couple of years outbreaks for different infections have deteriorated the situation. All these reports direct towards the increasing need for immunological diagnosis and treatment for infections across the world. Therefore the market for this infection oncology may grow with significant rate in near future. On the other hand high cost involved and limited reach of this technology may hinder the growth of the market.

However the growth of the market may be significant in emerging economies in Asia and Africa considering high incidence and prevalence rate for infections. This market can also be segmented according various categories of infections such as hepatitis viruses, retroviruses and other infections. The market has different classes of products used such as reagents, diagnostic kits, instruments and others.

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023.

Europe precision medicine market size, by application, 2013 - 2023 (USD Million)

Statistics of Physicians, Researchers and Academicians working on Molecular Medicine and Oncology section.

Academia 35%

Researchers 35%

Physicians 25%

Others 5%

Oncology Drug Market: Overview

Development of some new drugs with success rate is expected to offer the good opportunity for oncology drug market. Wide-ranging scope of Immuno-oncology agents in different cancer treatments would provide the maximum share to oncology drug market in the forecast period. Pharmaceutical companies and R&D are showing increased interest in this field and is expected to offer better potential for oncology drug market. Companies involved in partnership and R&D for efficient technologies is some of the latest trends that have been observed in oncology drug market. Currently, most of the oncology drugs are in clinical trial and are expected to rise the oncology market after clearance or success of these products from clinical trials.

Growth rate of Oncology research:

A new report from business intelligence provider GBI Research - Global Oncology Market to 2022 - states that the global oncology treatment market is set to expand from the $61.5 billion in 2015 to an estimated $74.2 billion in 2022, despite the imminent expiry of a host of oncology treatments.

Oncology Drug Market: Key Market Participants

Currently various established companies in diagnostic and healthcare segment catering varied range of products such as reagents, test kits and instruments in this market out of which companies such as F. Hoffmann-La Roche Ltd., Abbott Laboratories, Shanghai Kehua Bio-engineering Co., Ltd, Trans Asia Bio-Medicals Ltd, Span Diagnostics Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. are leading contributors in reagents and test kits, on the other hand Siemens Healthcare and PerkinElmer, Inc. are major companies in Instruments segment.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include